Global Classical Swine Fever Vaccines Supply, Demand and Key Producers, 2024-2030
Page: 142
Published Date: 09 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Classical Swine Fever Vaccines market size is expected to reach $ 215.2 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).
The global classical swine fever vaccine market is dominated by Winsun, Boehringer Ingelheim and CAHIC, with the top three manufacturers accounting for about 37% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 70%, followed by Europe with a market share of about 15%. Tissue Culture Origin is the main type, with a share about 66%. Market Sales is the main application, which holds a share about 95%.
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
This report studies the global Classical Swine Fever Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Classical Swine Fever Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Classical Swine Fever Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Classical Swine Fever Vaccines total production and demand, 2019-2030, (M Doses)
Global Classical Swine Fever Vaccines total production value, 2019-2030, (USD Million)
Global Classical Swine Fever Vaccines production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (M Doses)
Global Classical Swine Fever Vaccines consumption by region & country, CAGR, 2019-2030 & (M Doses)
U.S. VS China: Classical Swine Fever Vaccines domestic production, consumption, key domestic manufacturers and share
Global Classical Swine Fever Vaccines production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (M Doses)
Global Classical Swine Fever Vaccines production by Source, production, value, CAGR, 2019-2030, (USD Million) & (M Doses)
Global Classical Swine Fever Vaccines production by Sales Channel production, value, CAGR, 2019-2030, (USD Million) & (M Doses).
This reports profiles key players in the global Classical Swine Fever Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include WINSUN, Merck, CAHIC, Tecon, SPAH, Boehringer Ingelheim, Ceva, Harbin Veterinary Research Institute and Qilu Animal Health Products Factory, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Classical Swine Fever Vaccines market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (US$/K Doses) by manufacturer, by Source, and by Sales Channel. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Classical Swine Fever Vaccines Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Classical Swine Fever Vaccines Market, Segmentation by Source
Tissue Culture Origin
Cell Line Origin
Global Classical Swine Fever Vaccines Market, Segmentation by Sales Channel
Government Tender
Market Sales
Companies Profiled:
WINSUN
Merck
CAHIC
Tecon
SPAH
Boehringer Ingelheim
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Key Questions Answered
1. How big is the global Classical Swine Fever Vaccines market?
2. What is the demand of the global Classical Swine Fever Vaccines market?
3. What is the year over year growth of the global Classical Swine Fever Vaccines market?
4. What is the production and production value of the global Classical Swine Fever Vaccines market?
5. Who are the key producers in the global Classical Swine Fever Vaccines market?
Table of Contents
1 Supply Summary
1.1 Classical Swine Fever Vaccines Introduction
1.2 World Classical Swine Fever Vaccines Supply & Forecast
1.2.1 World Classical Swine Fever Vaccines Production Value (2019 & 2023 & 2030)
1.2.2 World Classical Swine Fever Vaccines Production (2019-2030)
1.2.3 World Classical Swine Fever Vaccines Pricing Trends (2019-2030)
1.3 World Classical Swine Fever Vaccines Production by Region (Based on Production Site)
1.3.1 World Classical Swine Fever Vaccines Production Value by Region (2019-2030)
1.3.2 World Classical Swine Fever Vaccines Production by Region (2019-2030)
1.3.3 World Classical Swine Fever Vaccines Average Price by Region (2019-2030)
1.3.4 North America Classical Swine Fever Vaccines Production (2019-2030)
1.3.5 Europe Classical Swine Fever Vaccines Production (2019-2030)
1.3.6 South Korea Classical Swine Fever Vaccines Production (2019-2030)
1.3.7 China Classical Swine Fever Vaccines Production (2019-2030)
1.3.8 Southeast Asia Classical Swine Fever Vaccines Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Classical Swine Fever Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Classical Swine Fever Vaccines Major Market Trends
2.1 World Classical Swine Fever Vaccines Demand (2019-2030)
2.2 World Classical Swine Fever Vaccines Consumption by Region
2.2.1 World Classical Swine Fever Vaccines Consumption by Region (2019-2024)
2.2.2 World Classical Swine Fever Vaccines Consumption Forecast by Region (2025-2030)
2.3 United States Classical Swine Fever Vaccines Consumption (2019-2030)
2.4 China Classical Swine Fever Vaccines Consumption (2019-2030)
2.5 Europe Classical Swine Fever Vaccines Consumption (2019-2030)
2.6 Japan Classical Swine Fever Vaccines Consumption (2019-2030)
2.7 South Korea Classical Swine Fever Vaccines Consumption (2019-2030)
2.8 ASEAN Classical Swine Fever Vaccines Consumption (2019-2030)
2.9 India Classical Swine Fever Vaccines Consumption (2019-2030)
3.1 World Classical Swine Fever Vaccines Production Value by Manufacturer (2019-2024)
3.2 World Classical Swine Fever Vaccines Production by Manufacturer (2019-2024)
3.3 World Classical Swine Fever Vaccines Average Price by Manufacturer (2019-2024)
3.4 Classical Swine Fever Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Classical Swine Fever Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Classical Swine Fever Vaccines in 2023
3.5.3 Global Concentration Ratios (CR8) for Classical Swine Fever Vaccines in 2023
3.6 Classical Swine Fever Vaccines Market: Overall Company Footprint Analysis
3.6.1 Classical Swine Fever Vaccines Market: Region Footprint
3.6.2 Classical Swine Fever Vaccines Market: Company Product Type Footprint
3.6.3 Classical Swine Fever Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Classical Swine Fever Vaccines Production Value Comparison
4.1.1 United States VS China: Classical Swine Fever Vaccines Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Classical Swine Fever Vaccines Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Classical Swine Fever Vaccines Production Comparison
4.2.1 United States VS China: Classical Swine Fever Vaccines Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Classical Swine Fever Vaccines Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Classical Swine Fever Vaccines Consumption Comparison
4.3.1 United States VS China: Classical Swine Fever Vaccines Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Classical Swine Fever Vaccines Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Classical Swine Fever Vaccines Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Classical Swine Fever Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Classical Swine Fever Vaccines Production Value (2019-2024)
4.4.3 United States Based Manufacturers Classical Swine Fever Vaccines Production (2019-2024)
4.5 China Based Classical Swine Fever Vaccines Manufacturers and Market Share
4.5.1 China Based Classical Swine Fever Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Classical Swine Fever Vaccines Production Value (2019-2024)
4.5.3 China Based Manufacturers Classical Swine Fever Vaccines Production (2019-2024)
4.6 Rest of World Based Classical Swine Fever Vaccines Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Classical Swine Fever Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Classical Swine Fever Vaccines Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Classical Swine Fever Vaccines Production (2019-2024)
5.1 World Classical Swine Fever Vaccines Market Size Overview by Source: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Source
5.2.1 Tissue Culture Origin
5.2.2 Cell Line Origin
5.3 Market Segment by Source
5.3.1 World Classical Swine Fever Vaccines Production by Source (2019-2030)
5.3.2 World Classical Swine Fever Vaccines Production Value by Source (2019-2030)
5.3.3 World Classical Swine Fever Vaccines Average Price by Source (2019-2030)
6.1 World Classical Swine Fever Vaccines Market Size Overview by Sales Channel: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Sales Channel
6.2.1 Government Tender
6.2.2 Market Sales
6.3 Market Segment by Sales Channel
6.3.1 World Classical Swine Fever Vaccines Production by Sales Channel (2019-2030)
6.3.2 World Classical Swine Fever Vaccines Production Value by Sales Channel (2019-2030)
6.3.3 World Classical Swine Fever Vaccines Average Price by Sales Channel (2019-2030)
7.1 WINSUN
7.1.1 WINSUN Details
7.1.2 WINSUN Major Business
7.1.3 WINSUN Classical Swine Fever Vaccines Product and Services
7.1.4 WINSUN Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 WINSUN Recent Developments/Updates
7.1.6 WINSUN Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Classical Swine Fever Vaccines Product and Services
7.2.4 Merck Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 CAHIC
7.3.1 CAHIC Details
7.3.2 CAHIC Major Business
7.3.3 CAHIC Classical Swine Fever Vaccines Product and Services
7.3.4 CAHIC Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 CAHIC Recent Developments/Updates
7.3.6 CAHIC Competitive Strengths & Weaknesses
7.4 Tecon
7.4.1 Tecon Details
7.4.2 Tecon Major Business
7.4.3 Tecon Classical Swine Fever Vaccines Product and Services
7.4.4 Tecon Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Tecon Recent Developments/Updates
7.4.6 Tecon Competitive Strengths & Weaknesses
7.5 SPAH
7.5.1 SPAH Details
7.5.2 SPAH Major Business
7.5.3 SPAH Classical Swine Fever Vaccines Product and Services
7.5.4 SPAH Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 SPAH Recent Developments/Updates
7.5.6 SPAH Competitive Strengths & Weaknesses
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Details
7.6.2 Boehringer Ingelheim Major Business
7.6.3 Boehringer Ingelheim Classical Swine Fever Vaccines Product and Services
7.6.4 Boehringer Ingelheim Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Boehringer Ingelheim Recent Developments/Updates
7.6.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.7 Ceva
7.7.1 Ceva Details
7.7.2 Ceva Major Business
7.7.3 Ceva Classical Swine Fever Vaccines Product and Services
7.7.4 Ceva Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Ceva Recent Developments/Updates
7.7.6 Ceva Competitive Strengths & Weaknesses
7.8 Harbin Veterinary Research Institute
7.8.1 Harbin Veterinary Research Institute Details
7.8.2 Harbin Veterinary Research Institute Major Business
7.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product and Services
7.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Harbin Veterinary Research Institute Recent Developments/Updates
7.8.6 Harbin Veterinary Research Institute Competitive Strengths & Weaknesses
7.9 Qilu Animal Health Products Factory
7.9.1 Qilu Animal Health Products Factory Details
7.9.2 Qilu Animal Health Products Factory Major Business
7.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product and Services
7.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Qilu Animal Health Products Factory Recent Developments/Updates
7.9.6 Qilu Animal Health Products Factory Competitive Strengths & Weaknesses
7.10 Ringpu Biology
7.10.1 Ringpu Biology Details
7.10.2 Ringpu Biology Major Business
7.10.3 Ringpu Biology Classical Swine Fever Vaccines Product and Services
7.10.4 Ringpu Biology Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Ringpu Biology Recent Developments/Updates
7.10.6 Ringpu Biology Competitive Strengths & Weaknesses
7.11 DHN
7.11.1 DHN Details
7.11.2 DHN Major Business
7.11.3 DHN Classical Swine Fever Vaccines Product and Services
7.11.4 DHN Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 DHN Recent Developments/Updates
7.11.6 DHN Competitive Strengths & Weaknesses
7.12 CAVAC
7.12.1 CAVAC Details
7.12.2 CAVAC Major Business
7.12.3 CAVAC Classical Swine Fever Vaccines Product and Services
7.12.4 CAVAC Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 CAVAC Recent Developments/Updates
7.12.6 CAVAC Competitive Strengths & Weaknesses
7.13 Komipharm
7.13.1 Komipharm Details
7.13.2 Komipharm Major Business
7.13.3 Komipharm Classical Swine Fever Vaccines Product and Services
7.13.4 Komipharm Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Komipharm Recent Developments/Updates
7.13.6 Komipharm Competitive Strengths & Weaknesses
7.14 Agrovet
7.14.1 Agrovet Details
7.14.2 Agrovet Major Business
7.14.3 Agrovet Classical Swine Fever Vaccines Product and Services
7.14.4 Agrovet Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Agrovet Recent Developments/Updates
7.14.6 Agrovet Competitive Strengths & Weaknesses
7.15 Bioveta
7.15.1 Bioveta Details
7.15.2 Bioveta Major Business
7.15.3 Bioveta Classical Swine Fever Vaccines Product and Services
7.15.4 Bioveta Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Bioveta Recent Developments/Updates
7.15.6 Bioveta Competitive Strengths & Weaknesses
7.16 Jinyu Bio-Technology
7.16.1 Jinyu Bio-Technology Details
7.16.2 Jinyu Bio-Technology Major Business
7.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Product and Services
7.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Jinyu Bio-Technology Recent Developments/Updates
7.16.6 Jinyu Bio-Technology Competitive Strengths & Weaknesses
7.17 Institutul Pasteur
7.17.1 Institutul Pasteur Details
7.17.2 Institutul Pasteur Major Business
7.17.3 Institutul Pasteur Classical Swine Fever Vaccines Product and Services
7.17.4 Institutul Pasteur Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Institutul Pasteur Recent Developments/Updates
7.17.6 Institutul Pasteur Competitive Strengths & Weaknesses
7.18 MVP
7.18.1 MVP Details
7.18.2 MVP Major Business
7.18.3 MVP Classical Swine Fever Vaccines Product and Services
7.18.4 MVP Classical Swine Fever Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 MVP Recent Developments/Updates
7.18.6 MVP Competitive Strengths & Weaknesses
8.1 Classical Swine Fever Vaccines Industry Chain
8.2 Classical Swine Fever Vaccines Upstream Analysis
8.2.1 Classical Swine Fever Vaccines Core Raw Materials
8.2.2 Main Manufacturers of Classical Swine Fever Vaccines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Classical Swine Fever Vaccines Production Mode
8.6 Classical Swine Fever Vaccines Procurement Model
8.7 Classical Swine Fever Vaccines Industry Sales Model and Sales Channels
8.7.1 Classical Swine Fever Vaccines Sales Model
8.7.2 Classical Swine Fever Vaccines Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Classical Swine Fever Vaccines Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Classical Swine Fever Vaccines Production Value by Region (2019-2024) & (USD Million)
Table 3. World Classical Swine Fever Vaccines Production Value by Region (2025-2030) & (USD Million)
Table 4. World Classical Swine Fever Vaccines Production Value Market Share by Region (2019-2024)
Table 5. World Classical Swine Fever Vaccines Production Value Market Share by Region (2025-2030)
Table 6. World Classical Swine Fever Vaccines Production by Region (2019-2024) & (M Doses)
Table 7. World Classical Swine Fever Vaccines Production by Region (2025-2030) & (M Doses)
Table 8. World Classical Swine Fever Vaccines Production Market Share by Region (2019-2024)
Table 9. World Classical Swine Fever Vaccines Production Market Share by Region (2025-2030)
Table 10. World Classical Swine Fever Vaccines Average Price by Region (2019-2024) & (US$/K Doses)
Table 11. World Classical Swine Fever Vaccines Average Price by Region (2025-2030) & (US$/K Doses)
Table 12. Classical Swine Fever Vaccines Major Market Trends
Table 13. World Classical Swine Fever Vaccines Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (M Doses)
Table 14. World Classical Swine Fever Vaccines Consumption by Region (2019-2024) & (M Doses)
Table 15. World Classical Swine Fever Vaccines Consumption Forecast by Region (2025-2030) & (M Doses)
Table 16. World Classical Swine Fever Vaccines Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Classical Swine Fever Vaccines Producers in 2023
Table 18. World Classical Swine Fever Vaccines Production by Manufacturer (2019-2024) & (M Doses)
Table 19. Production Market Share of Key Classical Swine Fever Vaccines Producers in 2023
Table 20. World Classical Swine Fever Vaccines Average Price by Manufacturer (2019-2024) & (US$/K Doses)
Table 21. Global Classical Swine Fever Vaccines Company Evaluation Quadrant
Table 22. World Classical Swine Fever Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Classical Swine Fever Vaccines Production Site of Key Manufacturer
Table 24. Classical Swine Fever Vaccines Market: Company Product Type Footprint
Table 25. Classical Swine Fever Vaccines Market: Company Product Application Footprint
Table 26. Classical Swine Fever Vaccines Competitive Factors
Table 27. Classical Swine Fever Vaccines New Entrant and Capacity Expansion Plans
Table 28. Classical Swine Fever Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Classical Swine Fever Vaccines Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Classical Swine Fever Vaccines Production Comparison, (2019 & 2023 & 2030) & (M Doses)
Table 31. United States VS China Classical Swine Fever Vaccines Consumption Comparison, (2019 & 2023 & 2030) & (M Doses)
Table 32. United States Based Classical Swine Fever Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Classical Swine Fever Vaccines Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Classical Swine Fever Vaccines Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Classical Swine Fever Vaccines Production (2019-2024) & (M Doses)
Table 36. United States Based Manufacturers Classical Swine Fever Vaccines Production Market Share (2019-2024)
Table 37. China Based Classical Swine Fever Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Classical Swine Fever Vaccines Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Classical Swine Fever Vaccines Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Classical Swine Fever Vaccines Production (2019-2024) & (M Doses)
Table 41. China Based Manufacturers Classical Swine Fever Vaccines Production Market Share (2019-2024)
Table 42. Rest of World Based Classical Swine Fever Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Classical Swine Fever Vaccines Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Classical Swine Fever Vaccines Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Classical Swine Fever Vaccines Production (2019-2024) & (M Doses)
Table 46. Rest of World Based Manufacturers Classical Swine Fever Vaccines Production Market Share (2019-2024)
Table 47. World Classical Swine Fever Vaccines Production Value by Source, (USD Million), 2019 & 2023 & 2030
Table 48. World Classical Swine Fever Vaccines Production by Source (2019-2024) & (M Doses)
Table 49. World Classical Swine Fever Vaccines Production by Source (2025-2030) & (M Doses)
Table 50. World Classical Swine Fever Vaccines Production Value by Source (2019-2024) & (USD Million)
Table 51. World Classical Swine Fever Vaccines Production Value by Source (2025-2030) & (USD Million)
Table 52. World Classical Swine Fever Vaccines Average Price by Source (2019-2024) & (US$/K Doses)
Table 53. World Classical Swine Fever Vaccines Average Price by Source (2025-2030) & (US$/K Doses)
Table 54. World Classical Swine Fever Vaccines Production Value by Sales Channel, (USD Million), 2019 & 2023 & 2030
Table 55. World Classical Swine Fever Vaccines Production by Sales Channel (2019-2024) & (M Doses)
Table 56. World Classical Swine Fever Vaccines Production by Sales Channel (2025-2030) & (M Doses)
Table 57. World Classical Swine Fever Vaccines Production Value by Sales Channel (2019-2024) & (USD Million)
Table 58. World Classical Swine Fever Vaccines Production Value by Sales Channel (2025-2030) & (USD Million)
Table 59. World Classical Swine Fever Vaccines Average Price by Sales Channel (2019-2024) & (US$/K Doses)
Table 60. World Classical Swine Fever Vaccines Average Price by Sales Channel (2025-2030) & (US$/K Doses)
Table 61. WINSUN Basic Information, Manufacturing Base and Competitors
Table 62. WINSUN Major Business
Table 63. WINSUN Classical Swine Fever Vaccines Product and Services
Table 64. WINSUN Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. WINSUN Recent Developments/Updates
Table 66. WINSUN Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Classical Swine Fever Vaccines Product and Services
Table 70. Merck Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. CAHIC Basic Information, Manufacturing Base and Competitors
Table 74. CAHIC Major Business
Table 75. CAHIC Classical Swine Fever Vaccines Product and Services
Table 76. CAHIC Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. CAHIC Recent Developments/Updates
Table 78. CAHIC Competitive Strengths & Weaknesses
Table 79. Tecon Basic Information, Manufacturing Base and Competitors
Table 80. Tecon Major Business
Table 81. Tecon Classical Swine Fever Vaccines Product and Services
Table 82. Tecon Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Tecon Recent Developments/Updates
Table 84. Tecon Competitive Strengths & Weaknesses
Table 85. SPAH Basic Information, Manufacturing Base and Competitors
Table 86. SPAH Major Business
Table 87. SPAH Classical Swine Fever Vaccines Product and Services
Table 88. SPAH Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. SPAH Recent Developments/Updates
Table 90. SPAH Competitive Strengths & Weaknesses
Table 91. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 92. Boehringer Ingelheim Major Business
Table 93. Boehringer Ingelheim Classical Swine Fever Vaccines Product and Services
Table 94. Boehringer Ingelheim Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Boehringer Ingelheim Recent Developments/Updates
Table 96. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 97. Ceva Basic Information, Manufacturing Base and Competitors
Table 98. Ceva Major Business
Table 99. Ceva Classical Swine Fever Vaccines Product and Services
Table 100. Ceva Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Ceva Recent Developments/Updates
Table 102. Ceva Competitive Strengths & Weaknesses
Table 103. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 104. Harbin Veterinary Research Institute Major Business
Table 105. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product and Services
Table 106. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Harbin Veterinary Research Institute Recent Developments/Updates
Table 108. Harbin Veterinary Research Institute Competitive Strengths & Weaknesses
Table 109. Qilu Animal Health Products Factory Basic Information, Manufacturing Base and Competitors
Table 110. Qilu Animal Health Products Factory Major Business
Table 111. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product and Services
Table 112. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Qilu Animal Health Products Factory Recent Developments/Updates
Table 114. Qilu Animal Health Products Factory Competitive Strengths & Weaknesses
Table 115. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 116. Ringpu Biology Major Business
Table 117. Ringpu Biology Classical Swine Fever Vaccines Product and Services
Table 118. Ringpu Biology Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Ringpu Biology Recent Developments/Updates
Table 120. Ringpu Biology Competitive Strengths & Weaknesses
Table 121. DHN Basic Information, Manufacturing Base and Competitors
Table 122. DHN Major Business
Table 123. DHN Classical Swine Fever Vaccines Product and Services
Table 124. DHN Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. DHN Recent Developments/Updates
Table 126. DHN Competitive Strengths & Weaknesses
Table 127. CAVAC Basic Information, Manufacturing Base and Competitors
Table 128. CAVAC Major Business
Table 129. CAVAC Classical Swine Fever Vaccines Product and Services
Table 130. CAVAC Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. CAVAC Recent Developments/Updates
Table 132. CAVAC Competitive Strengths & Weaknesses
Table 133. Komipharm Basic Information, Manufacturing Base and Competitors
Table 134. Komipharm Major Business
Table 135. Komipharm Classical Swine Fever Vaccines Product and Services
Table 136. Komipharm Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Komipharm Recent Developments/Updates
Table 138. Komipharm Competitive Strengths & Weaknesses
Table 139. Agrovet Basic Information, Manufacturing Base and Competitors
Table 140. Agrovet Major Business
Table 141. Agrovet Classical Swine Fever Vaccines Product and Services
Table 142. Agrovet Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Agrovet Recent Developments/Updates
Table 144. Agrovet Competitive Strengths & Weaknesses
Table 145. Bioveta Basic Information, Manufacturing Base and Competitors
Table 146. Bioveta Major Business
Table 147. Bioveta Classical Swine Fever Vaccines Product and Services
Table 148. Bioveta Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Bioveta Recent Developments/Updates
Table 150. Bioveta Competitive Strengths & Weaknesses
Table 151. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 152. Jinyu Bio-Technology Major Business
Table 153. Jinyu Bio-Technology Classical Swine Fever Vaccines Product and Services
Table 154. Jinyu Bio-Technology Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Jinyu Bio-Technology Recent Developments/Updates
Table 156. Jinyu Bio-Technology Competitive Strengths & Weaknesses
Table 157. Institutul Pasteur Basic Information, Manufacturing Base and Competitors
Table 158. Institutul Pasteur Major Business
Table 159. Institutul Pasteur Classical Swine Fever Vaccines Product and Services
Table 160. Institutul Pasteur Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Institutul Pasteur Recent Developments/Updates
Table 162. MVP Basic Information, Manufacturing Base and Competitors
Table 163. MVP Major Business
Table 164. MVP Classical Swine Fever Vaccines Product and Services
Table 165. MVP Classical Swine Fever Vaccines Production (M Doses), Price (US$/K Doses), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 166. Global Key Players of Classical Swine Fever Vaccines Upstream (Raw Materials)
Table 167. Classical Swine Fever Vaccines Typical Customers
Table 168. Classical Swine Fever Vaccines Typical Distributors
List of Figure
Figure 1. Classical Swine Fever Vaccines Picture
Figure 2. World Classical Swine Fever Vaccines Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Classical Swine Fever Vaccines Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Classical Swine Fever Vaccines Production (2019-2030) & (M Doses)
Figure 5. World Classical Swine Fever Vaccines Average Price (2019-2030) & (US$/K Doses)
Figure 6. World Classical Swine Fever Vaccines Production Value Market Share by Region (2019-2030)
Figure 7. World Classical Swine Fever Vaccines Production Market Share by Region (2019-2030)
Figure 8. North America Classical Swine Fever Vaccines Production (2019-2030) & (M Doses)
Figure 9. Europe Classical Swine Fever Vaccines Production (2019-2030) & (M Doses)
Figure 10. South Korea Classical Swine Fever Vaccines Production (2019-2030) & (M Doses)
Figure 11. China Classical Swine Fever Vaccines Production (2019-2030) & (M Doses)
Figure 12. Southeast Asia Classical Swine Fever Vaccines Production (2019-2030) & (M Doses)
Figure 13. Classical Swine Fever Vaccines Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Classical Swine Fever Vaccines Consumption (2019-2030) & (M Doses)
Figure 16. World Classical Swine Fever Vaccines Consumption Market Share by Region (2019-2030)
Figure 17. United States Classical Swine Fever Vaccines Consumption (2019-2030) & (M Doses)
Figure 18. China Classical Swine Fever Vaccines Consumption (2019-2030) & (M Doses)
Figure 19. Europe Classical Swine Fever Vaccines Consumption (2019-2030) & (M Doses)
Figure 20. Japan Classical Swine Fever Vaccines Consumption (2019-2030) & (M Doses)
Figure 21. South Korea Classical Swine Fever Vaccines Consumption (2019-2030) & (M Doses)
Figure 22. ASEAN Classical Swine Fever Vaccines Consumption (2019-2030) & (M Doses)
Figure 23. India Classical Swine Fever Vaccines Consumption (2019-2030) & (M Doses)
Figure 24. Producer Shipments of Classical Swine Fever Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Classical Swine Fever Vaccines Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Classical Swine Fever Vaccines Markets in 2023
Figure 27. United States VS China: Classical Swine Fever Vaccines Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Classical Swine Fever Vaccines Production Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: Classical Swine Fever Vaccines Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States Based Manufacturers Classical Swine Fever Vaccines Production Market Share 2023
Figure 31. China Based Manufacturers Classical Swine Fever Vaccines Production Market Share 2023
Figure 32. Rest of World Based Manufacturers Classical Swine Fever Vaccines Production Market Share 2023
Figure 33. World Classical Swine Fever Vaccines Production Value by Source, (USD Million), 2019 & 2023 & 2030
Figure 34. World Classical Swine Fever Vaccines Production Value Market Share by Source in 2023
Figure 35. Tissue Culture Origin
Figure 36. Cell Line Origin
Figure 37. World Classical Swine Fever Vaccines Production Market Share by Source (2019-2030)
Figure 38. World Classical Swine Fever Vaccines Production Value Market Share by Source (2019-2030)
Figure 39. World Classical Swine Fever Vaccines Average Price by Source (2019-2030) & (US$/K Doses)
Figure 40. World Classical Swine Fever Vaccines Production Value by Sales Channel, (USD Million), 2019 & 2023 & 2030
Figure 41. World Classical Swine Fever Vaccines Production Value Market Share by Sales Channel in 2023
Figure 42. Government Tender
Figure 43. Market Sales
Figure 44. World Classical Swine Fever Vaccines Production Market Share by Sales Channel (2019-2030)
Figure 45. World Classical Swine Fever Vaccines Production Value Market Share by Sales Channel (2019-2030)
Figure 46. World Classical Swine Fever Vaccines Average Price by Sales Channel (2019-2030) & (US$/K Doses)
Figure 47. Classical Swine Fever Vaccines Industry Chain
Figure 48. Classical Swine Fever Vaccines Procurement Model
Figure 49. Classical Swine Fever Vaccines Sales Model
Figure 50. Classical Swine Fever Vaccines Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
WINSUN Merck CAHIC Tecon SPAH Boehringer Ingelheim Ceva Harbin Veterinary Research Institute Qilu Animal Health Products Factory Ringpu Biology DHN CAVAC Komipharm Agrovet Bioveta Jinyu Bio-Technology Institutul Pasteur MVP
Related Reports
26 Jan 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
